Toviaz (fesoterodine fumarate): new drug to treat overactive bladder

FDA press release about the approval of Toviaz (fesoterodine fumarate): The U.S. Food and Drug Administration has approved a new drug to help patients suffering from overactive bladder (OAB). Toviaz (fesoterodine fumarate) works by relaxing the smooth muscle tissue of the bladder, thus reducing the urinary frequency, urge to urinate, and sudden urinary incontinence (leakage […]

Are you a visual learner interested in learning psychopharmacology? Click here to get our videos